Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ThredUp Inc (TDUP) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

ThredUp IncTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

ThredUp Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? ThredUp Inc trades at $2.2 (market cap $303.38M), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Vir Biotechnology Inc. Common Stock is far larger — about 5.9× ThredUp Inc's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, ThredUp Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ThredUp Inc for 29 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

TDUPVIR
Market Cap
$303.38M$1.80B
Volume
1,426,0251,782,836
Sector
Consumer CyclicalHealth
52-Week High
$9.38$11.78
52-Week Low
$2.12$5.12
Typical Hold Time
29 Days0 Days
Enterprise Value
$301.56M$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ThredUp Inc

ThredUp (TDUP) trades at $2.2, down 11.29% in the last session, with a bullish technical signal from moving averages but mixed oscillators. The company reported record Q2 2026 revenue of $90.8 million, up 17% year-over-year, but missed EPS estimates and cut full-year revenue guidance. Cash flow from operations improved to $10.65 million in 2025, though net income remains negative. Analyst consensus is 57% buy, with no sell ratings, but recent news highlights promotional headwinds and a securities investigation.

The outlook is cautious; revenue growth and high gross margins are positives, but persistent losses, weak guidance, and legal risks pose challenges. The stock's low price-to-sales ratio of 0.88 may attract value investors, yet profitability concerns and negative ROE of -36.76% underscore significant execution risk. Investors should weigh strong analyst support against fundamental weaknesses and market sentiment shifts.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TDUP
88% Buy12% Sell
Avg holding period · 29 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About ThredUp Inc

ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.

Read more on TDUP →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →